Avenue Therapeutics, Inc.
ATXI
|
NASDAQ
|
0 Sledující
Company Quality
Profitability Score
9/100
Solvency Score
50/100
Dividends
Dividends data currently unavailable.Earnings
8/7/2025
in 60 days
-
Revenue est.
-
EPS est.
My Notes
You haven't added any notes for this stock yet. Use this space to record your insights or strategies.
Profile
Healthcare
Sektor
Biotechnology
Průmysl
Dr. Alexandra MacLean M.D.
CEO
2
Zaměstnanci
New York
Centrála
US
Země
Key Metrics TTM
Valuation
Market cap.
$637KEnterprise Value
-$2.9MPrice to Earnings
-0.04Price to Sales
0.00Price to Book
0.17Price to Cash Flow
-0.09Profitability
Return on Assets
-380.02%Return on Equity
-399.33%Return on Invested Capital
-422.80%Gross Margin
0.00%Operating Margin
0.00%Net Margin
0.00%Liquidity
Quick Ratio
2.77Current Ratio
2.77Cash Ratio
2.77Inventory Turnover
0.00Asset Turnover
0.00Total Liabilities
$1.3MSolvency
Debt to Assets
0.00Debt to Equity
N/AInterest Coverage
0.00Equity Ratio
0.65Long-term Debt to Cap.
0.00Altman Z-Score
-44.08Performance
Earnings Waterfall
Debt level and coverage
Earnings
Feed
There are no posts to show right now.